These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23571536)

  • 1. Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae.
    Ceccarelli G; Falcone M; Giordano A; Mezzatesta ML; Caio C; Stefani S; Venditti M
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2900-1. PubMed ID: 23571536
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems.
    Hong JH; Clancy CJ; Cheng S; Shields RK; Chen L; Doi Y; Zhao Y; Perlin DS; Kreiswirth BN; Nguyen MH
    Antimicrob Agents Chemother; 2013 May; 57(5):2147-53. PubMed ID: 23459476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae.
    Giamarellou H; Galani L; Baziaka F; Karaiskos I
    Antimicrob Agents Chemother; 2013 May; 57(5):2388-90. PubMed ID: 23439635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs.
    Hagihara M; Crandon JL; Urban C; Nicolau DP
    J Antimicrob Chemother; 2013 Jul; 68(7):1616-8. PubMed ID: 23475648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan.
    Chung KP; Tseng SP; Huang YT; Tsai TH; Teng LJ; Hsueh PR
    J Antimicrob Chemother; 2011 May; 66(5):1182-4. PubMed ID: 21393195
    [No Abstract]   [Full Text] [Related]  

  • 6. Doripenem MICs and ompK36 porin genotypes of sequence type 258, KPC-producing Klebsiella pneumoniae may predict responses to carbapenem-colistin combination therapy among patients with bacteremia.
    Shields RK; Nguyen MH; Potoski BA; Press EG; Chen L; Kreiswirth BN; Clarke LG; Eschenauer GA; Clancy CJ
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1797-801. PubMed ID: 25534733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae.
    Wiskirchen DE; Crandon JL; Nicolau DP
    Int J Antimicrob Agents; 2013 Jun; 41(6):582-5. PubMed ID: 23611306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of humanized carbapenem exposures against New Delhi metallo-β-lactamase (NDM-1)-producing enterobacteriaceae in a murine infection model.
    Wiskirchen DE; Nordmann P; Crandon JL; Nicolau DP
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3936-40. PubMed ID: 23733463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae.
    Cprek JB; Gallagher JC
    Antimicrob Agents Chemother; 2016 Jan; 60(1):669-73. PubMed ID: 26552970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections.
    Oliva A; D'Abramo A; D'Agostino C; Iannetta M; Mascellino MT; Gallinelli C; Mastroianni CM; Vullo V
    J Antimicrob Chemother; 2014 Jun; 69(6):1718-20. PubMed ID: 24521856
    [No Abstract]   [Full Text] [Related]  

  • 11. The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniae.
    Jernigan MG; Press EG; Nguyen MH; Clancy CJ; Shields RK
    Antimicrob Agents Chemother; 2012 Jun; 56(6):3395-8. PubMed ID: 22430958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin.
    Clancy CJ; Chen L; Hong JH; Cheng S; Hao B; Shields RK; Farrell AN; Doi Y; Zhao Y; Perlin DS; Kreiswirth BN; Nguyen MH
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5258-65. PubMed ID: 23939888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model.
    Wiskirchen DE; Nordmann P; Crandon JL; Nicolau DP
    Antimicrob Agents Chemother; 2014; 58(3):1678-83. PubMed ID: 24379200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
    Oliva A; Scorzolini L; Cipolla A; Mascellino MT; Cancelli F; Castaldi D; D'Abramo A; D'Agostino C; Russo G; Ciardi MR; Mastroianni CM; Vullo V
    J Antimicrob Chemother; 2017 Jul; 72(7):1981-1984. PubMed ID: 28369424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae.
    Tascini C; Tagliaferri E; Giani T; Leonildi A; Flammini S; Casini B; Lewis R; Ferranti S; Rossolini GM; Menichetti F
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3990-3. PubMed ID: 23752510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneumoniae strains with various ompK36 genotypes.
    Clancy CJ; Hao B; Shields RK; Chen L; Perlin DS; Kreiswirth BN; Nguyen MH
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3521-5. PubMed ID: 24566172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiological efficiency of the combinations of two carbapenems against antibiotic resistant Klebsiella pneumoniae strains.
    Tapalski DV; Timoshkova EV; Petrovskaya TA; Osipkina OV; Karpov IA
    Klin Lab Diagn; 2021 May; 66(5):304-309. PubMed ID: 34047517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.
    Machuca I; Gutiérrez-Gutiérrez B; Gracia-Ahufinger I; Rivera Espinar F; Cano Á; Guzmán-Puche J; Pérez-Nadales E; Natera C; Rodríguez M; León R; Castón JJ; Rodríguez-López F; Rodríguez-Baño J; Torre-Cisneros J
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258.
    Bogdanovich T; Adams-Haduch JM; Tian GB; Nguyen MH; Kwak EJ; Muto CA; Doi Y
    Clin Infect Dis; 2011 Aug; 53(4):373-6. PubMed ID: 21810751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility.
    Lee NY; Lee CC; Huang WH; Tsui KC; Hsueh PR; Ko WC
    Antimicrob Agents Chemother; 2012 Jun; 56(6):2888-93. PubMed ID: 22430969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.